|
Volumn 37, Issue 7, 2002, Pages 863-865
|
Favorable response to infliximab treatment in a patient with active Crohn disease and Pyoderma gangrenosum
a a a a
a
NONE
(Greece)
|
Author keywords
Crohn disease; Extraintestinal manifestation; Infliximab; Pyoderma gangrenosum
|
Indexed keywords
CHIMERIC ANTIBODY;
CORTICOSTEROID;
INFLIXIMAB;
ORNIDAZOLE;
PREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA;
GASTROINTESTINAL AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
BODY WEIGHT;
CASE REPORT;
CLINICAL FEATURE;
CONTROLLED STUDY;
CROHN DISEASE;
DISEASE COURSE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
LABORATORY TEST;
PRIORITY JOURNAL;
PYODERMA GANGRENOSUM;
REMISSION;
SKIN DEFECT;
TREATMENT OUTCOME;
DRUG ANTAGONISM;
ILEITIS;
MIDDLE AGED;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
ILEITIS;
MIDDLE AGED;
PYODERMA GANGRENOSUM;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035988917
PISSN: 00365521
EISSN: None
Source Type: Journal
DOI: 10.1080/gas.37.7.863.865 Document Type: Article |
Times cited : (43)
|
References (13)
|